Posted on 10/26/2021 3:51:59 PM PDT by Jedediah
Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza. A Phase 2b/3 clinical trial recently published in The Lancet Infectious Diseases found that oral administration of nitazoxanide 600 mg twice daily for five days reduced the duration of clinical symptoms and reduced viral shedding compared to placebo in persons with laboratory-confirmed influenza. The same study also suggested a potential benefit for subjects with influenza-like illness who did not have influenza or other documented respiratory viral infection. From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication. Nitazoxanide is orally bioavailable and safe with extensive post-marketing experience involving more than 75 million adults and children. A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors. It is synergistic with neuraminidase inhibitors, and combination therapy with oseltamivir is being studied in humans as part of ongoing Phase 3 clinical development. Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.
I don’t want anything they’re selling.
ANOTHER Tami-Flu?
Exactly,
Inhibit This!
Clot Shots Kill!
No, this is an anti-protozoan similar to HCQ or Ivermectin.
This is already included in the FLCCC’s early COVID-19 treatment protocol. Like ivermectin, it is a repurposed anti-parasitic
Ivermectin and Nitazoxanide Combination Therapy for COVID-19
Don't see any updates. Gee, wonder why...
* antiprotozoal agent, aka, anti parasite
* broad-spectrum antiviral drug
* repurposed
Where have I heard this story before?
The ONLY thing that matters is whether it still has patent protection and can make some company a TON of money. If it off-patent, then nobody will recommend it.
Ouch. My eyes.
Add some paragraphs FCOL.
Note to conservative kids in need of Halloween costume ideas: Have one kid dress as a box of Ivermectin, one kid can be a cowboy, and any other kids can be horses!
If I get them at my door: EXTRA CANDY!
I read an article about BioNTech yesterday at CNBC, the business channel.
BioNTech is a German company that specializes in mRNA vaccines.
Pfizer partnered with BioNTech to get a COVID vaccine to market with the greatest possible speed.
The article mentions that Pfizer has been testing a mRNA influenza vaccine since 2019.
Get that?
Pfizer is still testing its mRNA flu vaccine after THREE years.
But, miraculously, they developed and distributed a mRNA COVID vaccine within 10 months.
This is no more legible than your word salads.
Grammar makes writing more intelligible.
Try it in bird seed for a few years and get back to us.
Just curious. Why is this in the Religion forum?
the ANTICOV study in Africa is all about low cost proven drugs. It’s being run in 18 african nations. They’re trialing Nitazoxanide which is pretty cheap. Ivermectin is being widely phased out because of drug resistance.
https://journals.asm.org/doi/10.1128/AAC.00713-16
https://pubmed.ncbi.nlm.nih.gov/27246778/
Nitazoxanide inhibits host enzymes, which impairs the posttranslational processing of viral proteins. It also has inhibitory effects on proinflammatory cytokines.
In mexico its $30 for 12 500mg pills
Amixicile is a lquid form and has amazing
Capabilities to search the body for gram negative bacteria and block their proteins as it wipes them out systemically
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.